CtrlK
Madrigal Pharmaceuticals
MDGL52
$326.74arrow_drop_down0.11%-$0.36
NASDAQ - As of Apr 4, 2:14 PM EDT Market Open
High Growth
MDGL52
$326.74
arrow_drop_down0.11%Performance History
There's no data available for performance history chart
There's no data available for key stats
There's no data available for ratios/profitability stats
Score Breakdown
Welcome to Stocklytics
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Analyst Forecast
Period: Next 12 Months
•Predicted: just now
info
Analyzed by 29 Wall Street experts, Madrigal Pharmaceuticals 's 12-month projections average at $327.41, spanning from a high of $425.00 to a low of $150.00. This signifies an 2.86% shift from the current price of $326.74.
Analyst Ratings
Buy
| Buy | 14 | 87.50% | |
|---|---|---|---|
| Hold | 1 | 6.25% | |
| Sell | 1 | 6.25% |
•Ratings from: April•
Last updated: just now
•Total: 16info
Analyst ratings for this stock instrument are based on analysts' assumptions and should not be solely relied upon for financial decisions.
Correlated Companies
About Madrigal Pharmaceuticals (MDGL)
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Dr. Paul A. Friedman M.D.
- Headquarters
- West Conshohocken
- Employees
- 92
- Exchange
- NASDAQ
Keep an eye on Madrigal Pharmaceuticals
Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Frequently Asked Questions
help
What is Madrigal Pharmaceuticals 's (MDGL) price per share?
The current price per share for Madrigal Pharmaceuticals (MDGL) is $326.74. The stock has seen a price change of -$0.36 recently, indicating a -0.11% change. This reflects the stock's recent market performance and investor sentiment.
help
What is the 52-week high and low for Madrigal Pharmaceuticals (MDGL)?
For Madrigal Pharmaceuticals (MDGL), the 52-week high is $376.7, which is 15.29% from the current price. The 52-week low is $119.76, the current price is 172.83% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help
Is Madrigal Pharmaceuticals (MDGL) a growth stock?
Madrigal Pharmaceuticals (MDGL) has shown an average price growth of -1.65% over the past three years. It has received a score of 91 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Madrigal Pharmaceuticals as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help
What is Madrigal Pharmaceuticals (MDGL) stock price performance year to date (YTD)?
As of the latest data, Madrigal Pharmaceuticals (MDGL) has a year-to-date price change of 5.89%. Over the past month, the stock has experienced a price change of 4.23%. Over the last three months, the change has been 2.21%. Over the past six months, the figure is 58.17%. Looking at a longer horizon, the five-year price change stands at 443.39%.
help
Is Madrigal Pharmaceuticals (MDGL) a profitable company?
Madrigal Pharmaceuticals (MDGL) has a net income of -$465.89M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -64.84% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $180.13M, although specific revenue growth data is currently not available. The gross profit is $173.9M. Operating income is noted at -$497.88M. Furthermore, the EBITDA is -$496.78M.
help
What is the market capitalization of Madrigal Pharmaceuticals (MDGL)?
Madrigal Pharmaceuticals (MDGL) has a market capitalization of $7.22B. The average daily trading volume is 326.74, indicating the stock's liquidity and investor engagement.